Signals that Control Thymocyte Migration
- Institution
- UNIVERSITY OF CALIFORNIA BERKELEY, CA
- Principal investigator
- Ellen A Robey
- Funding
- $468K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Abstract: The choice of developing T cells to adopt the CD4 helper or CD8 killer cell fate is a valuable model for understanding mammalian cell fate decisions and is a key step in shaping the adaptive immune response. While it is known that TCR recognition of self pMHC ligands in the thymus controls cell fate, the molecular links between TCR signaling and the activation of the lineage-defining transcriptional networks remains unknown. Guided by a high-resolution single cell map of T cell development, we propose to define the molecular links between different branches of the TCR signaling pathway and the transcriptional network that specifies the CD4 fate (Aim 1). We will also probe the factors that determine why thymocytes that recognize MHC-2 fully activate this network, whereas thymocytes that recognize MHC-1 do not (Aim 2). The proposed studies will reveal fundamental principles underlying mammalian cell fate decisions and help to understand the molecular mechanisms that link the killer versus helper T cell effector functional programs to the recognition of MHC 1 versus 2.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA BERKELEY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California BerkeleyNot yet scored
Immunology & Molecular Medicine Program Training Grant
Gregory M Barton · $488K · 2012–2029
- NIH · University of California Berkeley48
Leveraging Single Cell Stimulation to Untangle Parallel Perceptual Pathways in the Human Retina
Leah Johnston · $47K · 2024–2027
- NIH · University of California Berkeley48
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
John F Hartwig · $832K · 2019–2027